Primary Mpox and Secondary Syphilis in an HIV Patient: A Community Hospital Experience

By sjmartinez • April 14, 2023

Castanares GG, D'Assumpcao C, Fang M, McPheeters R, Heidari A. Primary Mpox and Secondary Syphilis in an HIV Patient: A Community Hospital Experience. J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231165739. doi: 10.1177/23247096231165739. PMID: 37052123; PMCID: PMC10102933.

Tags: HIV, Infectious Diseases, Kern, mpox, non-variola orthopoxvirus, syphilis

Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial

Edupuganti S, Hurt CB, Stephenson KE, Huang Y, Paez CA, Yu C, Yen C, Hanscom B, He Z, Miner MD, Gamble T, Heptinstall J, Seaton[...]

Cluster of Extensively Drug-Resistant Shigella sonnei Carrying blaCTX-M-15 in Los Angeles, California, 2023-2024

Caldera JR, Shaw B, Uslan DZ, Yang S. Cluster of Extensively Drug-Resistant Shigella sonnei Carrying blaCTX-M-15 in Los Angeles, California, 2023-2024. Am J Infect Control. 2024[...]

Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status

Lo Re V 3rd, Newcomb CW, Carbonari DM, Mezochow AK, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa[...]